Meeting Highlights
Coverage of the 2008 Annual Scientific Meeting of the American College of Rheumatology, San Francisco, CA, October 24-29, 2008
Coverage of the 2008 Congress of the European League Against Rheumatism, Paris, France, June 11-14, 2008
Honolulu, September 14-19, 2007
Notes from the 2007 Meeting of the Global Arthritis Research Network
News from the 8th International Congress
Affiliations
Arthritis News
Wednesday, December 17, 2008
Early RA Shows as MRI Hand Tenosynovitis
MRI readily detects early arthritis as flexor tenosynovitis...
Thursday, December 11, 2008
One-Shot Synvisc Gets FDA Panel OK
An FDA advisory panel has unanimously recommended approval of Genzyme's Synvisc-One™ single-dose hyalin for knee OA pain...
Wednesday, December 10, 2008
US-Guided Synvisc, Steroids Ease Inoperable Shoulders
Ultrasound-guided hyaluronic acid and steroid offer an alternative for inoperable shoulder impingement syndrome and arthrosynovitis...
Thursday, December 04, 2008
RA Improving Due to Better Management, Not New Drugs
Better monitoring and more aggressive use of old drugs, especially methotrexate, have contributed more to recent improvements in RA outcomes in Spain than the arrival of new drugs such as TNF inhibitors...
Thursday, December 04, 2008
FDA Panel Okays Febuxostat for Gout
A US FDA panel voted 12-0 this week to recommend approval of Takeda Pharmaceutical's febuxostat (Uloric®), the first new gout drug in 40 years...
Tuesday, November 25, 2008
Who Stays in RA Remission After TNF Blockade Stops?
Patients who start treatment soon after RA symptoms appear, and who have increased functional T-cells, higher levels of interleukin-10, and lower levels of interleukin-12 maintain sustained remission even after stopping TNF-blockers...
Monday, November 24, 2008
New OA Topicals Ease Pain, Protect Stomach
New topical NSAID formulations relieve OA pain without the GI problems associated with oral NSAIDs...
Friday, November 21, 2008
EntreMed Reports Antiangiogenic Role of 2ME2 Demonstrated in RA Models
Preclinical results for 2ME2 (Panzem® or 2-methoxyestradiol) in rheumatoid arthritis demonstrated that 2ME2 involutes rat collagen-induced arthritis and suppresses synovial VEGF and bFGF gene expression...
Thursday, November 20, 2008
New Therapy Could Transform Arthritis Treatment
Researchers have genetically engineered a modified form of the molecule Foxp3 which helps regulate the body’s immune system and may have important implications for the treatment of rheumatoid arthritis…
Tuesday, November 18, 2008
Centocor's Golimumab Gives Durable Skin, Joint Relief in Psoriatic Arthritis, ACR Studies Say
More than half of active psoriatic arthritis patients receiving subcutaneous injections of 50 mg or 100 mg of golimumab (CNTO 148) every 4 weeks showed improvements that lasted through 1 year in the joint and skin symptoms...
